Cargando…

Efficacy and safety of Jiu-Wei-Xi-Feng granules for treating tic disorders in children: study protocol for a randomized controlled equivalence trial

BACKGROUND: Tic disorders (TD) is a neuropsychiatric disease with twitch as the main manifestation in childhood. Jiu-Wei-Xi-Feng granules has been marketed in China for treating children with TD. As Long Gu (Os Draconis) in the composition of this Chinese patent medicine is a rare and expensive medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Sheng-xuan, Li, Rui-ben, Hu, Si-yuan, Cai, Qiu-han, Zhong, Cheng-liang, Hao, Rui-min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587639/
https://www.ncbi.nlm.nih.gov/pubmed/36273181
http://dx.doi.org/10.1186/s13063-022-06802-y
_version_ 1784813951173787648
author Guo, Sheng-xuan
Li, Rui-ben
Hu, Si-yuan
Cai, Qiu-han
Zhong, Cheng-liang
Hao, Rui-min
author_facet Guo, Sheng-xuan
Li, Rui-ben
Hu, Si-yuan
Cai, Qiu-han
Zhong, Cheng-liang
Hao, Rui-min
author_sort Guo, Sheng-xuan
collection PubMed
description BACKGROUND: Tic disorders (TD) is a neuropsychiatric disease with twitch as the main manifestation in childhood. Jiu-Wei-Xi-Feng granules has been marketed in China for treating children with TD. As Long Gu (Os Draconis) in the composition of this Chinese patent medicine is a rare and expensive medicinal material protected by the Chinese government, therefore, we consider replacing it with Mu Li (Concha Ostreae) that has the same effect and is cheaper. This study is designed to evaluate the clinical equivalence between Jiu-Wei-Xi-Feng granules (Os Draconis replaced by Concha Ostreae) (JWXFD) and Jiu-Wei-Xi-Feng granules (original formula) (JWXFO) in children with TD (consumption of renal yin and liver wind stirring up internally syndrome). METHODS/DESIGN: This is a multicenter, randomized, double-blind, equivalence trial comparing the efficacy and safety of JWXFD and JWXFO in treating Children with tic disorders (consumption of renal yin and liver wind stirring up internally syndrome). A total of 288 patients will be recruited and randomly assigned to two groups in a 1:1 ratio. The treatment course is 6 weeks, with a 2 weeks follow-up. The primary outcome is the mean change value from baseline to 6th week by the Yale Global Tic Severity Scale total tic score (YGTSS-TTS). Secondary outcomes include total effective rate of tic, Yale Global Tic Severity Scale (YGTSS) scores and its factor scores (the degree of motor tics, phonic tics and social function damage), Clinical Global Impression-Severity scale, and TCM syndrome efficacy. DISCUSSION: The design of this study refers to a large number of similar research design points, and asked for opinions of peer experts, and finally reached a consensus. This trial will provide high-quality evidence on the clinical equivalence between JWXFD and JWXFO and provide a basis for the marketing of JWXFD. TRIAL REGISTRATION: ChiCTR2000032312 Registered on 25 April 2020, http://www.chictr.org.cn/showproj.aspx?proj=52630
format Online
Article
Text
id pubmed-9587639
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95876392022-10-23 Efficacy and safety of Jiu-Wei-Xi-Feng granules for treating tic disorders in children: study protocol for a randomized controlled equivalence trial Guo, Sheng-xuan Li, Rui-ben Hu, Si-yuan Cai, Qiu-han Zhong, Cheng-liang Hao, Rui-min Trials Study Protocol BACKGROUND: Tic disorders (TD) is a neuropsychiatric disease with twitch as the main manifestation in childhood. Jiu-Wei-Xi-Feng granules has been marketed in China for treating children with TD. As Long Gu (Os Draconis) in the composition of this Chinese patent medicine is a rare and expensive medicinal material protected by the Chinese government, therefore, we consider replacing it with Mu Li (Concha Ostreae) that has the same effect and is cheaper. This study is designed to evaluate the clinical equivalence between Jiu-Wei-Xi-Feng granules (Os Draconis replaced by Concha Ostreae) (JWXFD) and Jiu-Wei-Xi-Feng granules (original formula) (JWXFO) in children with TD (consumption of renal yin and liver wind stirring up internally syndrome). METHODS/DESIGN: This is a multicenter, randomized, double-blind, equivalence trial comparing the efficacy and safety of JWXFD and JWXFO in treating Children with tic disorders (consumption of renal yin and liver wind stirring up internally syndrome). A total of 288 patients will be recruited and randomly assigned to two groups in a 1:1 ratio. The treatment course is 6 weeks, with a 2 weeks follow-up. The primary outcome is the mean change value from baseline to 6th week by the Yale Global Tic Severity Scale total tic score (YGTSS-TTS). Secondary outcomes include total effective rate of tic, Yale Global Tic Severity Scale (YGTSS) scores and its factor scores (the degree of motor tics, phonic tics and social function damage), Clinical Global Impression-Severity scale, and TCM syndrome efficacy. DISCUSSION: The design of this study refers to a large number of similar research design points, and asked for opinions of peer experts, and finally reached a consensus. This trial will provide high-quality evidence on the clinical equivalence between JWXFD and JWXFO and provide a basis for the marketing of JWXFD. TRIAL REGISTRATION: ChiCTR2000032312 Registered on 25 April 2020, http://www.chictr.org.cn/showproj.aspx?proj=52630 BioMed Central 2022-10-22 /pmc/articles/PMC9587639/ /pubmed/36273181 http://dx.doi.org/10.1186/s13063-022-06802-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Guo, Sheng-xuan
Li, Rui-ben
Hu, Si-yuan
Cai, Qiu-han
Zhong, Cheng-liang
Hao, Rui-min
Efficacy and safety of Jiu-Wei-Xi-Feng granules for treating tic disorders in children: study protocol for a randomized controlled equivalence trial
title Efficacy and safety of Jiu-Wei-Xi-Feng granules for treating tic disorders in children: study protocol for a randomized controlled equivalence trial
title_full Efficacy and safety of Jiu-Wei-Xi-Feng granules for treating tic disorders in children: study protocol for a randomized controlled equivalence trial
title_fullStr Efficacy and safety of Jiu-Wei-Xi-Feng granules for treating tic disorders in children: study protocol for a randomized controlled equivalence trial
title_full_unstemmed Efficacy and safety of Jiu-Wei-Xi-Feng granules for treating tic disorders in children: study protocol for a randomized controlled equivalence trial
title_short Efficacy and safety of Jiu-Wei-Xi-Feng granules for treating tic disorders in children: study protocol for a randomized controlled equivalence trial
title_sort efficacy and safety of jiu-wei-xi-feng granules for treating tic disorders in children: study protocol for a randomized controlled equivalence trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587639/
https://www.ncbi.nlm.nih.gov/pubmed/36273181
http://dx.doi.org/10.1186/s13063-022-06802-y
work_keys_str_mv AT guoshengxuan efficacyandsafetyofjiuweixifenggranulesfortreatingticdisordersinchildrenstudyprotocolforarandomizedcontrolledequivalencetrial
AT liruiben efficacyandsafetyofjiuweixifenggranulesfortreatingticdisordersinchildrenstudyprotocolforarandomizedcontrolledequivalencetrial
AT husiyuan efficacyandsafetyofjiuweixifenggranulesfortreatingticdisordersinchildrenstudyprotocolforarandomizedcontrolledequivalencetrial
AT caiqiuhan efficacyandsafetyofjiuweixifenggranulesfortreatingticdisordersinchildrenstudyprotocolforarandomizedcontrolledequivalencetrial
AT zhongchengliang efficacyandsafetyofjiuweixifenggranulesfortreatingticdisordersinchildrenstudyprotocolforarandomizedcontrolledequivalencetrial
AT haoruimin efficacyandsafetyofjiuweixifenggranulesfortreatingticdisordersinchildrenstudyprotocolforarandomizedcontrolledequivalencetrial